Recession remains a threat ahead but there is cause for some optimism | Ed Conway

Business

Good news has been in such rare supply in economics recently that it’s worth dwelling on it when it arrives.

This morning, on Friday 13th of all days, the Office for National Statistics (ONS) announced that the economy had grown by 0.1% in November.

This is hardly especially strong gross domestic product growth, but it’s considerably better than what economists had expected: a 0.2% contraction.

And it’s significant because of what it implies.

Unless the economy contracts by 0.4% in December the UK could avoid falling into technical recession.

This is no mean feat. We are faced with one of the biggest price shocks in modern record.

The majority of economists, including the Bank of England and Office for Budget Responsibility, assumed that the economy would shrink in the final quarter of the year and, given a recession is typically defined as two successive quarters of contraction, that would mean we had formally succumbed to the R-word.

It’s now quite plausible that Britain avoids that fate – for the time being at least.

That final clause matters because whether or not the UK falls foul of this somewhat arbitrary economic phenomenon, its economy is still barely growing.

Read more
Bank of England’s bond market intervention achieves £3.8bn profit
What strong Christmas retail sales tell us about economy

Households are still squeezed and the squeeze is due to continue for some time to come. Much of the extra growth in November came courtesy of spending in pubs and hospitality during the World Cup.

Still, alongside other positive news – that wholesale gas prices are falling and that profits at many leading consumer-facing companies are holding up – this economic data might be the beginning of a more positive story for the UK economy.

The question now is how long that positivity lasts.

Products You May Like

Articles You May Like

NCIS Season 21 Episode 8 Review: Heartless
CrushFTP Zero-Day Flaw Exploited in Targeted Attacks
Book Riot’s Deals of the Day for April 20, 2024
FDA approves Pfizer gene therapy Beqvez for treatment of hemophilia B
Trump Media CEO says he’ll do ‘whatever it takes’ to defend DJT investors from short sellers